Two Day On-Site Conference on Point-of-Care, Biosensors and Rapid Diagnostics 2024 - Rotterdam, Netherlands - June 24-25, 2024
June 04, 2024 04:16 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Point-of-Care, Biosensors and Rapid Dx Europe 2024" conference has been added to ResearchAndMarkets.com's offering. The Point-of-Care, Biosensors...
Kymanox® Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings
June 03, 2024 10:16 ET
|
Kymanox
King of Prussia, Pennsylvania USA, June 03, 2024 (GLOBE NEWSWIRE) -- Kymanox is pleased to announce the expansion of its device design and testing facility in King of Prussia (KOP), PA, which will...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Life Science Technical Accounting CPE Update (2-Day Virtual Conference: September 17-18, 2024) - Understand the Latest Accounting Changes in Key Areas
May 24, 2024 07:32 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Life Science Technical Accounting CPE Update 2024" conference has been added to ResearchAndMarkets.com's offering. This conference will cover the...
$3.42 Billion NLP in Healthcare & Life Sciences Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2023 & 2024-2029F
May 08, 2024 07:22 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "NLP in Healthcare & Life Sciences Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 07, 2024 08:30 ET
|
Inozyme Pharma Inc.
Inozyme reported financial results for the first quarter ended March 31, 2024 and provided business highlights.
Life Science Tools Global Strategic Research Report 2024: Market to Reach $258.6 Billion by 2030 - Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
April 05, 2024 09:19 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Life Science Tools - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Life Science Tools Market to...
Global Glow Cell Assay Reagents Market Poised for Robust Growth and Technological Advancements by 2028
March 28, 2024 17:57 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Glow Cell Assay Reagents Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028" report has been added to ...
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
March 26, 2024 08:30 ET
|
Inozyme Pharma Inc.
Inozyme announced that it will host a conference call and webcast on Monday, Apr. 8, 2024 at 8:00 a.m. ET.
Business Information Market by Type (Commercial, Scientific, Technical, Medical, Educational and Training, and Others), End User (BFSI, Healthcare and Life Sciences, Manufacturing, Retail), and Region 2024-2032
March 25, 2024 19:47 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Business Information Market by Type (Commercial, Scientific, Technical, Medical, Educational and Training, and Others), End User (BFSI, Healthcare and...